Table 1 Patient characteristics
| Â | Total sample | |
|---|---|---|
(n = 620) | ||
M | SD | |
Age, mean years (SD) | 60.9 | 11.6 |
Duration of gout, years | 12.0 | 10.7 |
| Â | n | % |
Male | 504 | 81% |
Employed | 234 | 38% |
sUA level | ||
  Unknown | 448 | 72% |
  <6 mg/dL/360 μmol/L | 62 | 10% |
  6-8 mg/dL/360-480 μmol/L | 75 | 12% |
  >8 mg/dL/480 μmol/L | 35 | 6% |
Current medications | ||
  Allopurinol | 319 | 51% |
  Febuxostat | 29 | 5% |
  Probenecid | 18 | 3% |
  Benzbromarone | 4 | 1% |
  Other | 97 | 16% |
  None | 194 | 31% |
Flares in last 12 months | ||
  Don’t recall | 8 | 1% |
  0 | 143 | 23% |
  1-2 | 235 | 38% |
  3 | 91 | 15% |
  4-5 | 86 | 14% |
  6+ | 57 | 9% |
Tophi | ||
  Don’t know | 195 | 31% |
  0 | 349 | 56% |
  1 | 29 | 5% |
  2+ | 47 | 8% |